![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A01N 33/26 | |
A61K 31/655 | |||
A61P 1/06 | |||
A61P 1/00 |
(11) | Number of the document | 2563117 |
(13) | Kind of document | T |
(96) | European patent application number | 11775497.8 |
Date of filing the European patent application | 2011-04-26 | |
(97) | Date of publication of the European application | 2013-03-06 |
(45) | Date of publication and mention of the grant of the patent | 2018-02-21 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2011/033905 |
Date | 2011-04-26 |
(87) | Number | WO 2011/137103 |
Date | 2011-11-03 |
(30) | Number | Date | Country code |
328151 P | 2010-04-26 | US |
(72) |
FORBES, William, US
BORTEY, Enoch, US
JOHNSON, Lorin, US
|
(73) |
Salix Pharmaceuticals, Ltd.,
8510 Colonnade Center Drive, Raleigh, NC 27615,
US
|
(54) | FORMULATIONS AND USES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES FOR THE TREATMENT OF MALES |
FORMULATIONS AND USES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES FOR THE TREATMENT OF MALES |